It’s not every day that the Food and Drug Administration removes a warning letter from its web site. But the agency did just that recently when it pulled down a missive that was originally sent last year to Pacira Pharmaceuticals. And the removal comes just as a closely watched legal battle -- which, in part, turns on First Amendment rights -- heats up between the drug maker and the agency.
Indeed, as unusual as it is for the FDA to remove a letter, what makes this still more interesting is that it occurs amid a lawsuit Pacira filed recently accusing the FDA of overstepping its authority to thwart inappropriate marketing.
Read Full Article »